Moreover, tamoxifen, a selective estrogen receptor modulator (SERM), inhibits estrogen- and IGF-II-stimulated H295R adrenocortical cancer cell proliferation in vitro and reduces H295R xenografts growth [4]. The gene discussed is IGF2; the disease is adrenal cortex carcinoma.